💉 Another Bausch + Lomb purchase; VBI Vaccines and Brii Biosciences' hep B partnership; US FDA's updated risk-based inspection model

#379 | Eliminating cancer chromosomes; Enjoying idle time a sign of creativity; The health risks of air pollution

and

Jul 07, 2023

∙ Paid

Hello, and welcome back to The Kable. As always, this Friday Kable is a stranger to paywalls, so you should share it with every life sciences person you know; let them also partake in our ridiculous humour and lame wordplay.

Now that you’ve shared the joy, on to the news.

Bausch + Lomb just a few days ago bought Novartis’ Xiidra and other ophthalmology pr…

Keep reading with a 7-day free trial

Subscribe to The Kable to keep reading this post and get 7 days of free access to the full post archives.